bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/773762

A framework for testing different imputation methods for tabular datasets

Kossen, T.·Livne, M.·Madai, V. I.·Galinovic, I.·Frey, D.·Fiebach, J. B.
View original source ↗Export metadata ↓

Abstract

Background and purposeHandling missing values is a prevalent challenge in the analysis of clinical data. The rise of data-driven models demands an efficient use of the available data. Methods to impute missing values are thus crucial. Here, we developed a publicly available framework to test different imputation methods and compared their impact in a typical stroke clinical dataset as a use case.\n\nMethodsA clinical dataset based on the 1000Plus stroke study with 380 completed-entries patients was used. 13 common clinical parameters including numerical and categorical values were selected. Missing values in a missing-at-random (MAR) and missing-completely-at-random (MCAR) fashion from 0% to 60% were simulated and consequently imputed using the mean, hot-deck, multiple imputation by chained equations, expectation maximization method and listwise deletion. The performance was assessed by the root mean squared error, the absolute bias and the performance of a linear model for discharge mRS prediction.\n\nResultsListwise deletion was the worst performing method and started to be significantly worse than any imputation method from 2% (MAR) and 3% (MCAR) missing values on. The underlying missing value mechanism seemed to have a crucial influence on the identified best performing imputation method. Consequently no single imputation method outperformed all others. A significant performance drop of the linear model started from 11% (MAR+MCAR) and 18% (MCAR) missing values.\n\nConclusionsIn the presented case study of a typical clinical stroke dataset we confirmed that listwise deletion should be avoided for dealing with missing values. Our findings indicate that the underlying missing value mechanism and other dataset characteristics strongly influence the best choice of imputation method. For future studies with similar data structure, we thus suggest to use the developed framework in this study to select the most suitable imputation method for a given dataset prior to analysis.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kossen, T., Livne, M., Madai, V. I., Galinovic, I., Frey, D., Fiebach, J. B.. 2019-09-17. A framework for testing different imputation methods for tabular datasets. https://doi.org/10.1101/773762

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗